Research Detail

Home
Publications

Publications

  1. Berardi A*, Kaestner CL*, Ghitti M*, Quilici G, Cocomazzi P, Li J, Ballabio F, Zucchelli C, Knapp S, Licht JD, Musco G. The C-terminal PHDVC5HCH tandem domain of NSD2 is a combinatorial reader of unmodified H3K4 and tri-methylated H3K27 that regulates transcription of cell adhesion genes in multiple myeloma. Nucleic Acids Res. 2024 Dec 5; https://doi.org/10.1093/nar/gkae1121.
  2. Dupere-Richer D, Riva A, Barwick BG, Maji S, Casellas Roman H, Li J, De U, Sobh A, Quickstad G, Piper C, Kulis M, Ezponda T, Martín-Subero JI, Tonon G, Zhang W, Mitsiades CS, Boise LH, Bennett RL, Licht JD. KDM6A Regulates Immune Response Genes in Multiple Myeloma. Blood. 2024 Oct 3;144(14):1508-1520. 
  3. Nie DY*, Tabor JR*, Li J, Kutera M, St-Germain J, Hanley RP, Wolf EZ, Paulakonis E, Kenney TMG, Duan S, Shrestha S, Owens DDG, Pon A, Szewczyk M, Lamberto AJ, Menes M, Li F, Barsyte-Lovejoy D, Brown NG, Barsotti AM, Stamford AW, Collins JL, Wilson DJ, Raught B, Licht J, James L, Arrowsmith C. Recruitment of FBXO22 for Targeted Degradation of NSD2. Nat Chem Biol. 2024 Dec;20(12):1597-1607.
  4. Morozov VM, Riva A, Sarwar S, Kim WJ, Li J, Zhou L, Licht JD, Daaka Y, Ishov AM. HIRA-mediated loading of histone variant H3.3 controls androgen-induced transcription by regulation of AR/BRD4 complex assembly at enhancers. Nucleic Acids Res. 2023 Oct 27; 51(19):10194-10217.
  5. Li J, Hlavka-Zhang J, Shrimp JH, Piper C, Dupere-Richer D, Roth JS, Jing D, Casellas Roman HL, Troche C, Swaroop A, Kulis M, Oyer JA, Will CM, Shen M, Riva A, Bennett RL, Ferrando AA, Hall MD, Lock RB, Licht JD. PRC2 inhibitors overcome glucocorticoid resistance driven by NSD2 mutation in pediatric acute lymphoblastic leukemia. Cancer Discov. 2022; 12(1): 186-203.
  6. Venugopal K, Feng Y, Nowialis P, Xu H, Shabashvili DE, Berntsen CM, Kaur P, Krajcik KI, Taragjini C, Zaroogian Z, Casellas Román HL, Posada LM, Gunaratne C, Li J, Dupéré-Richer D, Bennett RL, Pondugula S, Riva A, Cogle CR, Opavsky R, Law BK, Bhaduri-McIntosh S, Kubicek S, Staber PB, Licht JD, Bird JE, Guryanova OA. DNMT3A harboring leukemia-associated mutations directs sensitivity to DNA damage at replication forks. Clin Cancer Res. 2022; 28(4): 756-769.
  7. Li L, Sheng P, Li T, Fields CJ, Hiers NM, Wang Y, Li J, Guardia CM, Licht JD, Xie M. Widespread microRNA degradation elements in target mRNAs can assist the encoded proteins. Genes Dev. 2021; 35(23-24): 1595-1609.
  8. Casellas Roman HL, Venugopal K, Feng Y, Shabashvili DE, Posada LM, Li J, Guryanova OA. DNMT3A alterations associated with myeloid malignancies dictate differential responses to hypomethylating agents. Leuk Res. 2020; 94: 106372.
  9. Jiang Y, Gao R, Cao C, Forbes L, Li J, Freeberg S, Fredenburg KM, Justice JM, Silver NL, Wu L, Varma S, West R, Licht JD, Zajac-Kaye M, Kentsis A, Kaye FJ. MYB-activated models for testing therapeutic agents in adenoid cystic carcinoma. Oral Oncol. 2019; 98: 147-155.
  10. Xie Y, Shi X, Sheng K, Han G, Li W, Zhao Q, Jiang B, Feng J, Li J#, Gu Y#. PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia. Mol Med Rep. 2019; 19 (2): 783-791.
  11. Zhang P, Chen Z, Li R, Guo Y, Shi H, Bai J, Yang H, Sheng M, Li Z, Li Z, Li J, Chen S, Yuan W, Cheng T, Xu M, Zhou Y, Yang FC. Loss of ASXL1 in the bone marrow niche dysregulates hematopoietic stem and progenitor cell fates. Cell Discov. 2018; 4:4.
  12. Yang H, Kurtenbach S, Guo Y, Lohse I, Durante MA, Li J, Li Z, Al-Ali H, Li L, Chen Z, Field MG, Zhang P, Chen S, Yamamoto S, Li Z, Zhou Y, Nimer SD, Harbour JW, Wahlestedt C, Xu M, Yang FC. Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies. Blood. 2018; 131(3): 328-341.
  13. Li J*, He F*, Zhang P*, Chen S, Shi H, Sun Y, Guo Y, Yang H, Man N, Greenblatt S, Li Z, Guo Z, Zhou Y, Wang L, Morey L, Williams S, Chen X, Wang QT, Nimer SD, Yu P, Wang QF, Xu M, Yang FC. Loss of Asxl2 leads to myeloid malignancies in mice. Nat Commun. 2017; 8: 15456.
  14. Li Z, Zhang P, Yan A, Guo Z, Ban Y, Li J, Chen S, Yang H, He Y, Li J, Guo Y, Zhang W, Hajiramezanali E, An H, Fajardo D, Harbour JW, Ruan Y, Nimer SD, Yu P, Chen X, Xu M, Yang FC. ASXL1 interacts with the cohesin complex to maintain chromatid separation and gene expression for normal hematopoiesis. Sci Adv. 2017; 3(1): e1601602.
  15. Lu S, Ge M, Zheng Y, Li J, Feng X, Feng S, Huang J, Feng Y, Yang D, Shi J, Chen F, Han ZC. CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia. Stem Cell Res Ther. 2017; 1; 8(1): 178.
  16. Yang Z, Han Z, Ji Y, Wang Y, Liang L, Chi Y, Yang S, Li L, Luo W, Li J, Chen D, Du W, Cao X, Zhuo G, Wang T, Han ZC. CD106 identifies a subpopulation of mesenchymal stem cells with unique immunomodulatory properties. PLoS One. 2013; 8(3): e59354.
  17. Li J, Yang S, Lu S, Zhao H, Feng J, Li W, Ma F, Ren Q, Liu B, Zhang L, Zheng Y, Han ZC. Differential gene expression profile associated with the abnormality of bone marrow mesenchymal stem cells in aplastic anemia. PLoS One. 2012; 7 (11): e47764.
  18. Li J, Lu S, Yang S, Xing W, Feng J, Li W, Zhao Q, Wu H, Ge M, Ma F, Zhao H, Liu B, Zhang L, Zheng Y, Han ZC. Impaired immunomodulatory ability of bone marrow mesenchymal stem cells on CD4 (+) T cells in aplastic anemia. Results Immunol. 2012; 2: 142-147.
  19. Li J, Zhao Q, Xing W, Feng J, Wu H, Li H, Ge M, Tian K, Li X, Zhou J, Liu B, Zhang L, Zheng Y, Han ZC. Interleukin-27 enhances the production of tumour necrosis factor-α and interferon-γ by bone marrow T lymphocytes in aplastic anaemia. Br J Haematol. 2011; 153 (6): 764-772.
  20. Li J, Wu H, Xing W, Yang S, Lu S, Du W, Yu J, Chen F, Zhang L, Han ZC. Interleukin-27 as a negative regulator of human neutrophil function. Scand J Immunol. 2010; 72 (4): 284-292. (Cover highlight)
  21. Li J, Zheng C, Han ZC. Abnormal immunity and stem/progenitor cells in acquired aplastic anemia. Crit Rev Oncol Hematol. 2010; 75 (2): 79-93.
microscopes-for-researchers-in-medical-laboratories-e1621147243234.jpg